Dr Reddy's Laboratories Total Current Assets 2010-2024 | RDY

Dr Reddy's Laboratories total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Dr Reddy's Laboratories total current assets for the quarter ending June 30, 2024 were $3.230B, a 26.07% increase year-over-year.
  • Dr Reddy's Laboratories total current assets for 2024 were $2.976B, a 18.19% increase from 2023.
  • Dr Reddy's Laboratories total current assets for 2023 were $2.518B, a 5.05% increase from 2022.
  • Dr Reddy's Laboratories total current assets for 2022 were $2.397B, a 18.25% increase from 2021.
Dr Reddy's Laboratories Annual Total Current Assets
(Millions of US $)
2024 $2,976
2023 $2,518
2022 $2,397
2021 $2,027
2020 $1,729
2019 $1,656
2018 $1,684
2017 $1,548
2016 $1,807
2015 $1,923
2014 $1,729
2013 $1,572
2012 $1,375
2011 $1,069
2010 $936
2009 $99
Dr Reddy's Laboratories Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $3,230
2024-03-31 $2,976
2023-12-31 $2,867
2023-09-30 $2,620
2023-06-30 $2,562
2023-03-31 $2,518
2022-12-31 $2,351
2022-09-30 $2,158
2022-06-30 $2,274
2022-03-31 $2,397
2021-12-31 $2,243
2021-09-30 $2,204
2021-06-30 $2,136
2021-03-31 $2,027
2020-12-31 $1,827
2020-09-30 $1,836
2020-06-30 $1,760
2020-03-31 $1,729
2019-12-31 $1,643
2019-09-30 $1,700
2019-06-30 $1,677
2019-03-31 $1,656
2018-12-31 $1,623
2018-09-30 $1,594
2018-06-30 $1,678
2018-03-31 $1,684
2017-12-31 $1,715
2017-09-30 $1,577
2017-06-30 $1,548
2017-03-31 $1,548
2016-12-31 $1,551
2016-09-30 $1,504
2016-06-30 $1,511
2016-03-31 $1,807
2015-12-31 $1,803
2015-09-30 $1,774
2015-06-30 $1,823
2015-03-31 $1,923
2014-12-31 $1,772
2014-09-30 $1,734
2014-06-30 $1,762
2014-03-31 $1,729
2013-12-31 $1,645
2013-09-30 $1,553
2013-06-30 $1,541
2013-03-31 $1,572
2012-12-31 $1,535
2012-09-30 $1,490
2012-06-30 $1,344
2012-03-31 $1,375
2011-12-31 $1,356
2011-09-30 $1,160
2011-06-30 $1,088
2011-03-31 $1,069
2010-12-31 $920
2010-09-30 $908
2010-06-30 $915
2010-03-31 $936
2009-12-31 $804
2009-09-30 $781
2009-06-30 $824
2009-03-31 $766
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $12.521B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Bausch Health Cos (BHC) Canada $3.439B 2.49
Amphastar Pharmaceuticals (AMPH) United States $2.335B 14.04
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00